HLB has increased its stake in HLB Therapeutics, strengthening its control over the latter. 

HLB said Tuesday that it has purchased 673,000 shares of HLB Therapeutics, increasing its stake to 6.25 percent from 5.51 percent.

Please refer to the following website for further details :HLB increases stake in HLB Therapeutics to 6.25%